Newly Diagnosed Immune Thrombocytopenia
Showing 1 - 25 of >10,000
Immune Thrombocytopenia Trial in Bristol (Mycophenolate Mofetil, Prednisolone)
Completed
- Immune Thrombocytopenia
- Mycophenolate Mofetil
- Prednisolone
-
Bristol, United KingdomUniversity Hospital Bristol NHS Foundation Trust
Oct 25, 2022
Immune Thrombocytopenia Trial in Beijing (Baricitinib 2 MG, Dexamethasone)
Recruiting
- Immune Thrombocytopenia
- Baricitinib 2 MG
- Dexamethasone
-
Beijing, China
- +9 more
Jul 11, 2023
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Immune Thrombocytopenia Trial in Beijing (Cyclosporine Oral Product, Prednisone)
Not yet recruiting
- Immune Thrombocytopenia
- Cyclosporine Oral Product
- Prednisone
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jul 14, 2022
Primary Immune Thrombocytopenia Trial in Spain (Romiplostim plus dexamethasone, Dexamethasone)
Recruiting
- Primary Immune Thrombocytopenia
- romiplostim plus dexamethasone
- Dexamethasone
-
Barcelona, Spain
- +14 more
Dec 22, 2022
Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)
Recruiting
- Immune Thrombocytopenia (ITP)
-
Mannheim, Baden-Wuerttemberg, Germany
- +24 more
Dec 19, 2022
Primary Immune Thrombocytopenia (ITP) Trial in Switzerland (Eltrombopag (Revolade®), standard therapy (without eltrombopag):
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Eltrombopag (Revolade®)
- standard therapy (without eltrombopag): HD-DXM
-
Aarau, Switzerland
- +5 more
Sep 5, 2022
Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)
Not yet recruiting
- Immune Thrombocytopenia
- Purpura, Thrombocytopenic
- Atorvastatin 20mg
- +2 more
-
Jinan, Shandong, ChinaQilu hospital, Shandong University
Aug 30, 2021
Primary Immune Thrombocytopenia Trial (2.5mg/d Hetrombopag)
Not yet recruiting
- Primary Immune Thrombocytopenia
- 2.5mg/d Hetrombopag
- (no location specified)
Mar 28, 2022
ITP, Immune Thrombocytopenia Trial in Beijing (Dexamethasone, Tacrolimus)
Recruiting
- ITP
- Immune Thrombocytopenia
-
Beijing, ChinaPeking University People's Hospital
Feb 5, 2021
Immune Thrombocytopenia Trial in Beijing (Dexamethasone, Acetylcysteine)
Unknown status
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Apr 28, 2020
Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)
Recruiting
- Glioblastoma
- +2 more
- TMZ
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Glioma, Malignant Trial in United States (biological, drug, radiation, other)
Active, not recruiting
- Glioma, Malignant
- AdV-tk
- +5 more
-
Los Angeles, California
- +7 more
Jan 30, 2023
Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Recruiting
- Polymyalgia Rheumatica (PMR)
- Giant Cell Arteritis (GCA)
- Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
- +3 more
-
Basel, SwitzerlandDepartment of Rheumatology University Hospital Basel
Aug 2, 2022
Glioblastoma Trial in Saint Louis (NeoVax, Nivolumab, Ipilimumab)
Terminated
- Glioblastoma
- NeoVax
- +4 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2021
Inflammatory and Immune Profiling of Kidney Tissue Obtained From
Completed
- Proteinuria
- +2 more
-
New York, New YorkThe Rogosin Institute
Feb 28, 2022
Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)
Recruiting
- Immune Thrombocytopenic Purpura
-
Valhalla, New YorkNew York Medical College
Aug 4, 2021
Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)
Recruiting
- Small Cell Lung Cancer
- Immunotherapy
- chronic psychological stress
-
Changsha, Hunan, ChinaDepartment of Oncology, The Second Xiangya Hospital, Central Sou
Jul 22, 2023
Lung Cancer, Chronic Stress Disorder, Immune Checkpoint Inhibitors Trial in Changsha (Gut microbiota detection, Peripheral
Recruiting
- Lung Cancer
- +2 more
- Gut microbiota detection
- Peripheral immune cells signature detaction
-
Changsha, Hunan, ChinaDepartment of Oncology, The Second Xiangya Hospital, Central Sou
Jul 26, 2022
Diabetes Type 1 and Fitness.
Recruiting
- Diabetes Mellitus
-
Poznan, PolandDepartment of Internal Medicine and Diabetiology Poznan Universi
Jul 7, 2021
Immune Thrombocytopenia Trial (VIT D)
Not yet recruiting
- Immune Thrombocytopenia
- VIT D
- (no location specified)
Oct 5, 2023